Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922164338> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2922164338 endingPage "500" @default.
- W2922164338 startingPage "491" @default.
- W2922164338 abstract "TAS-115 is an oral multikinase inhibitor targeting the MET proto-oncogene, vascular endothelial growth factor receptor, and colony-stimulating factor 1 receptor. We evaluated the efficacy and safety of TAS-115 in castration-resistant prostate cancer (CRPC) patients with bone metastases.This phase II study, conducted in Japan, comprised 2 cohorts of CRPC patients. Cohort A included patients with bone metastasis and no history of docetaxel; TAS-115 200 to 400 mg/d was administered with abiraterone and prednisone. Cohort B included patients with symptomatic multiple bone metastases, post- or unfit for docetaxel, randomized 1:1 to receive TAS-115 400 or 600 mg/d orally, once daily, in a repeated weekly schedule of 5 days on/2 days off. The primary endpoint was bone scan index (BSI) response rate at Week 12 in each dose group.Cohorts A and B included 24 and 26 patients, respectively. The 12-week BSI response rates for 200, 300, and 400 mg were 0%, 33.3%, and 16.7% in Cohort A, and for 400 and 600 mg were 7.1% and 25.0% in Cohort B. The best BSI response rates for 200, 300, and 400 mg were 0%, 66.7%, and 16.7% in Cohort A, and for 400 and 600 mg were 7.1% and 33.3% in Cohort B. A ≥ 30% reduction in BPI-SF score was shown in 57.7% of patients in Cohort B. The most frequent Grade ≥ 3 adverse drug reactions were hypophosphatemia (20.8%) in Cohort A and anemia (23.1%) in Cohort B.TAS-115 appears to demonstrate anti-tumor activity and acceptable tolerability in CRPC patients with bone metastases." @default.
- W2922164338 created "2019-03-22" @default.
- W2922164338 creator A5004714456 @default.
- W2922164338 creator A5011250166 @default.
- W2922164338 creator A5014625956 @default.
- W2922164338 creator A5046362015 @default.
- W2922164338 creator A5058934672 @default.
- W2922164338 creator A5085955274 @default.
- W2922164338 date "2021-12-01" @default.
- W2922164338 modified "2023-10-12" @default.
- W2922164338 title "A Phase II, Randomized, Open-Label, Multi-arm Study of TAS-115 for Castration-Resistant Prostate Cancer Patients With Bone Metastases" @default.
- W2922164338 cites W1972539651 @default.
- W2922164338 cites W1979055605 @default.
- W2922164338 cites W2065916018 @default.
- W2922164338 cites W2094554815 @default.
- W2922164338 cites W2094630005 @default.
- W2922164338 cites W2110534364 @default.
- W2922164338 cites W2123206529 @default.
- W2922164338 cites W2135375304 @default.
- W2922164338 cites W2141454098 @default.
- W2922164338 cites W2159810380 @default.
- W2922164338 cites W2161962336 @default.
- W2922164338 cites W2170476872 @default.
- W2922164338 cites W2237254160 @default.
- W2922164338 cites W2338741450 @default.
- W2922164338 cites W2471050799 @default.
- W2922164338 cites W2531522165 @default.
- W2922164338 cites W2725924624 @default.
- W2922164338 cites W2889646458 @default.
- W2922164338 cites W2954049938 @default.
- W2922164338 cites W2995734343 @default.
- W2922164338 cites W4237882759 @default.
- W2922164338 cites W876816957 @default.
- W2922164338 doi "https://doi.org/10.1016/j.clgc.2021.07.013" @default.
- W2922164338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34493431" @default.
- W2922164338 hasPublicationYear "2021" @default.
- W2922164338 type Work @default.
- W2922164338 sameAs 2922164338 @default.
- W2922164338 citedByCount "2" @default.
- W2922164338 countsByYear W29221643382023 @default.
- W2922164338 crossrefType "journal-article" @default.
- W2922164338 hasAuthorship W2922164338A5004714456 @default.
- W2922164338 hasAuthorship W2922164338A5011250166 @default.
- W2922164338 hasAuthorship W2922164338A5014625956 @default.
- W2922164338 hasAuthorship W2922164338A5046362015 @default.
- W2922164338 hasAuthorship W2922164338A5058934672 @default.
- W2922164338 hasAuthorship W2922164338A5085955274 @default.
- W2922164338 hasBestOaLocation W29221643381 @default.
- W2922164338 hasConcept C121608353 @default.
- W2922164338 hasConcept C126322002 @default.
- W2922164338 hasConcept C143998085 @default.
- W2922164338 hasConcept C168563851 @default.
- W2922164338 hasConcept C197934379 @default.
- W2922164338 hasConcept C203092338 @default.
- W2922164338 hasConcept C2775832370 @default.
- W2922164338 hasConcept C2777783956 @default.
- W2922164338 hasConcept C2777899217 @default.
- W2922164338 hasConcept C2780192828 @default.
- W2922164338 hasConcept C2781190966 @default.
- W2922164338 hasConcept C71924100 @default.
- W2922164338 hasConcept C72563966 @default.
- W2922164338 hasConceptScore W2922164338C121608353 @default.
- W2922164338 hasConceptScore W2922164338C126322002 @default.
- W2922164338 hasConceptScore W2922164338C143998085 @default.
- W2922164338 hasConceptScore W2922164338C168563851 @default.
- W2922164338 hasConceptScore W2922164338C197934379 @default.
- W2922164338 hasConceptScore W2922164338C203092338 @default.
- W2922164338 hasConceptScore W2922164338C2775832370 @default.
- W2922164338 hasConceptScore W2922164338C2777783956 @default.
- W2922164338 hasConceptScore W2922164338C2777899217 @default.
- W2922164338 hasConceptScore W2922164338C2780192828 @default.
- W2922164338 hasConceptScore W2922164338C2781190966 @default.
- W2922164338 hasConceptScore W2922164338C71924100 @default.
- W2922164338 hasConceptScore W2922164338C72563966 @default.
- W2922164338 hasFunder F4320311653 @default.
- W2922164338 hasIssue "6" @default.
- W2922164338 hasLocation W29221643381 @default.
- W2922164338 hasLocation W29221643382 @default.
- W2922164338 hasOpenAccess W2922164338 @default.
- W2922164338 hasPrimaryLocation W29221643381 @default.
- W2922164338 hasRelatedWork W122177069 @default.
- W2922164338 hasRelatedWork W2552482676 @default.
- W2922164338 hasRelatedWork W2568045406 @default.
- W2922164338 hasRelatedWork W2768013934 @default.
- W2922164338 hasRelatedWork W2768688864 @default.
- W2922164338 hasRelatedWork W2776594178 @default.
- W2922164338 hasRelatedWork W2912565296 @default.
- W2922164338 hasRelatedWork W2935114107 @default.
- W2922164338 hasRelatedWork W2999207890 @default.
- W2922164338 hasRelatedWork W4226040508 @default.
- W2922164338 hasVolume "19" @default.
- W2922164338 isParatext "false" @default.
- W2922164338 isRetracted "false" @default.
- W2922164338 magId "2922164338" @default.
- W2922164338 workType "article" @default.